Today, Q4 2016 EPS Estimates for PRA Health Sciences Inc. Increased by William Blair (PRAH)

Today, Q4 2016 EPS Estimates for PRA Health Sciences Inc. Increased by William Blair (PRAH)
PRA Health Sciences Inc. (NASDAQ:PRAH) – William Blair lifted their Q4 2016 earnings estimates for PRA Health Sciences in a report issued on Monday. William Blair analyst J. Kreger now forecasts that the firm will earn $0.64 per share for the quarter, up from their previous estimate of $0.63. William Blair also issued estimates for PRA Health Sciences’ FY2017 earnings at $2.84 EPS and FY2018 earnings at $3.31 EPS.

Other research analysts have also issued reports about the stock. Jefferies Group restated a “buy” rating and set a $57.00 price target on shares of PRA Health Sciences in a research report on Friday, July 29th. KeyCorp restated a “buy” rating on shares of PRA Health Sciences in a research report on Friday, November 4th. TheStreet upgraded shares of PRA Health Sciences from a “hold” rating to a “buy” rating in a research report on Monday, November 14th. Citigroup Inc. boosted their price target on shares of PRA Health Sciences from $55.00 to $66.00 and gave the company a “buy” rating in a research report on Thursday, September 22nd. Finally, Zacks Investment Research lowered shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a research report on Thursday, August 11th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $55.86.

Shares of PRA Health Sciences (NASDAQ:PRAH) opened at 55.06 on Thursday. The firm has a market capitalization of $3.38 billion, a P/E ratio of 42.75 and a beta of 0.61. PRA Health Sciences has a one year low of $35.60 and a one year high of $60.96. The firm’s 50-day moving average price is $54.94 and its 200-day moving average price is $49.68.

Hedge funds have recently bought and sold shares of the company. US Bancorp DE bought a new stake in PRA Health Sciences during the third quarter worth about $106,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in PRA Health Sciences by 7.0% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,025 shares of the company’s stock worth $114,000 after buying an additional 133 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in PRA Health Sciences by 120.5% in the third quarter. BNP Paribas Arbitrage SA now owns 2,093 shares of the company’s stock worth $118,000 after buying an additional 1,144 shares in the last quarter. Fuller & Thaler Asset Management Inc. bought a new stake in PRA Health Sciences during the third quarter worth about $124,000. Finally, BlackRock Inc. increased its stake in PRA Health Sciences by 26.0% in the second quarter. BlackRock Inc. now owns 2,399 shares of the company’s stock worth $100,000 after buying an additional 495 shares in the last quarter.

PRA Health Sciences Company Profile

Related posts

Leave a Comment